tiprankstipranks
Repligen Corp (RGEN)
NASDAQ:RGEN
US Market

Repligen (RGEN) Earnings Dates, Call Summary & Reports

Compare
940 Followers

Earnings Data

Report Date
Feb 20, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
0.41
Last Year’s EPS
0.33
Same Quarter Last Year
Based on 8 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 20, 2025
|
% Change Since: 7.92%
|
Next Earnings Date:Apr 30, 2025
Earnings Call Sentiment|Positive
Repligen's earnings call highlighted strong growth in the CDMO and equipment segments, successful execution of strategic priorities, and positive outlook for 2025. However, challenges in China and the protein segment, along with restructuring charges, were notable lowlights. Despite these challenges, the positive aspects, including strong revenue growth and strategic achievements, outweigh the negatives.
Company Guidance
During the Repligen Corporation's Fourth Quarter 2024 Earnings Conference Call, financial guidance for 2025 was provided. The company anticipates revenue growth between 8% to 12% on a reported basis, translating to $685 million to $710 million, with non-COVID revenue expected to increase by 10% to 14%. Adjusted gross margins are projected to be 51% to 52%, reflecting a 100 to 200 basis point expansion from 2024. Operating income margins are expected to improve to 14% to 15%, driven by volume leverage, pricing, and productivity, despite inflationary pressures. The adjusted EBITDA margin is forecasted to be 20% to 21%. The effective tax rate is anticipated to rise to 22% to 23%. Overall, the company is optimistic about achieving these targets due to strong order momentum, market recovery, and strategic priorities centered on innovation, margin expansion, and growth in Asia.
Strong Fourth Quarter Revenue
Repligen achieved a fourth quarter revenue of $167.5 million and full year revenue of $634.4 million, despite a $3.5 million exchange rate headwind, with a 13% revenue growth ex-COVID in Q4 versus the previous year.
CDMO and Equipment Segment Growth
Significant improvement in the CDMO business with sales and orders up high double digits sequentially. Equipment sales and orders also up more than 30% sequentially, contributing to overall growth.
Filtration and Analytics Performance
Filtration revenue and orders were strong, with the filtration franchise growing 14% for the full year. Analytics had a record quarter, with an 11% sequential and 8% year-over-year sales increase.
Strategic Priorities Achieved
Repligen executed on strategic priorities, including increasing the high probability funnel by 16% and launching innovative products like the KrosFlow RS 10 RPM system and AVIPure double-stranded RNA resin.
2025 Financial Guidance
Repligen projects 2025 revenue growth of 8% to 12% on a reported basis, with potential foreign exchange headwinds, aiming for low double-digit growth excluding COVID.
---

Repligen (RGEN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

RGEN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 30, 20252025 (Q1)
0.35 / -
0.28
Feb 20, 20252024 (Q4)
0.41 / 0.44
0.3333.33% (+0.11)
Nov 12, 20242024 (Q3)
0.34 / 0.43
0.2386.96% (+0.20)
Jul 30, 20242024 (Q2)
0.33 / 0.33
0.53-37.74% (-0.20)
May 01, 20242024 (Q1)
0.30 / 0.28
0.64-56.25% (-0.36)
Feb 21, 20242023 (Q4)
0.33 / 0.33
0.68-51.47% (-0.35)
Oct 31, 20232023 (Q3)
0.17 / 0.23
0.77-70.13% (-0.54)
Aug 02, 20232023 (Q2)
0.47 / 0.53
0.91-41.76% (-0.38)
May 02, 20232023 (Q1)
0.59 / 0.64
0.92-30.43% (-0.28)
Feb 22, 20232022 (Q4)
0.58 / 0.68
0.81-16.05% (-0.13)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

RGEN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 20, 2025$150.73$162.67+7.92%
Nov 12, 2024$139.51$148.59+6.51%
Jul 30, 2024$138.00$160.59+16.37%
May 01, 2024$164.20$158.36-3.56%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Repligen Corp (RGEN) report earnings?
Repligen Corp (RGEN) is schdueled to report earning on Feb 20, 2025, TBA Not Confirmed.
    What is Repligen Corp (RGEN) earnings time?
    Repligen Corp (RGEN) earnings time is at Feb 20, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is RGEN EPS forecast?
          RGEN EPS forecast for the fiscal quarter 2024 (Q4) is 0.41.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis